We begin with a detailed assessment of your medical history, metabolic health, eating patterns, and past weight loss experiences
The data on the role of these medications in weight loss is fairly clearmany trials point to weight loss in the 15% to 20% range
Tirzepatide reduces appetite and creates the caloric deficit needed for fat loss
Journal of General Internal Medicine
In obese T2DM patients, exenatide reduced putamen activity to high-calorie food pictures, while enhancing putamen responses to low-calorie food pictures [39,40]
Bubliz explains that GLP-1s have been helpful diabetes medications long before they became popular for weight loss. When GLP-1s are used for chronic weight management, they require a higher effective dose compared to their use in diabetes treatment like mounjaro and wegovy,